Chronic News and Research

RSS

Food, exercise and regular physical activity still key to American health

The American Cancer Society (ACS), American Diabetes Association (ADA), and American Heart Association (AHA) commend the U.S. Departments of Health and Human Services (DHHS) and Agriculture (USDA) on the release of the 2005 Dietary Guidelines for Americans.

17 Jan 2005

Scientific evidence on passive smoking is inconclusive

Scientific evidence on environmental tobacco smoke (ETS or so-called "passive smoking") is inconclusive and does not justify a total ban on smoking in public places, it was argued at a conference on public smoking in Edinburgh today.

17 Jan 2005

Smoking marijuana is associated with increased risk of many of the same symptoms as smoking cigarettes

Smoking marijuana is associated with increased risk of many of the same symptoms as smoking cigarettes--chronic bronchitis, coughing on most days, phlegm production, shortness of breath, and wheezing, according to a Yale study published in the Journal of General Internal Medicine.

13 Jan 2005

Soy may reduce risk of cardiovascular disease

Every 34 seconds, an American man or woman dies of cardiovascular disease. Now, research suggests that a diet rich in soybean oil can help. Two new studies shed light on the power of alpha-linolenic acid (ALA) to reduce heart disease risk. Soybean oil provides an excellent source of ALA, as do leafy greens, some nuts and flax.

12 Jan 2005

Added sugar in fruit-flavored drinks and cola-type soft drinks undoes the good done by vegetables

American preschoolers get about 14 to 17 teaspoons of added sugar a day, on average, mostly from fruit-flavored drinks, high-fat desserts and cola-type soft drinks which displace the grain, vegetable, fruit and dairy food groups and lower the quality of their diet, a Penn State study has shown.

12 Jan 2005

Major partnership with National Institute of Allergy and Infectious Diseases for Narhex Life Sciences

Australian drug specialist Narhex Life Sciences, has announced a partnership with one of the world’s foremost US medical research centres to evaluate its protease inhibitor Nar DG 35 Prodrug for its activity against Hepatitis C and SARS viruses.

12 Jan 2005

Researchers to test new leukemia drug

Chronic myeloid leukemia (CML) is a malignant cancer of the blood that affects people of all ages. While treatment is available for most of these patients, approximately 20 percent of them do not respond to it. Researchers at McGill teaching hospitals will soon study the effects of a new alternative therapy.

12 Jan 2005

Latest Canadian mad cow case poses no threat

The recently confirmed case of mad cow disease in Canada is an isolated case and does not represent a threat to the food chain, according to the Pan American Health Organization’s top expert on the issue.

12 Jan 2005

Campral, first new treatment for alcoholism in ten years

Forest Laboratories announced that Campral (acamprosate calcium) Delayed- Release Tablets are now available to physicians, patients and pharmacies nationwide.

12 Jan 2005

Patient education on aerosol therapy key to effective asthma control

New evidence-based guidelines for the selection of aerosol medication devices conclude that health-care providers should avoid basing device selection exclusively on device efficacy. Instead, the choice should be based on other patient-related factors.

10 Jan 2005

Scientists examine the role of small sputum macrophages in the widespread disease chronic obstructive bronchitis

COPD (chronic obstructive pulmonary disease) is one of the most common fatal diseases worldwide. In Germany alone, there are about 3-5 million patients affected. COPD includes both chronic obstructive bronchitis and emphysema. Both represent irreversible changes of the central and lower respiratory tract which are accompanied by coughing, mucus production and difficulty in breathing.

10 Jan 2005

Core promoter mutants of Hepatitis B Virus e Antigen associated with development of fulminant hepatitis and liver cancer

Scientists in Brown Medical School, Providence, USA, have found that core promoter mutants of Hepatitis B Virus e Antigen replicate at up to 10-fold higher levels in transfected human hepatoma cells than the wild-type virus.

9 Jan 2005

Pegylated interferon alfa-2b offers the best treatment option for people with chronic hepatitis B infection

Harry Janssen (Erasmus University Medical Centre, Rotterdam, Netherlands) and colleagues assessed whether combination treatment with pegylated interferon alfa-2b and the antiviral agent lamivudine was more efficacious in treating chronic hepatitis B infection than pegylated interferon alfa-2b therapy alone.

7 Jan 2005

Promising new evidence for the optimal use of biologic therapies for rheumatoid arthritis

A major cause of pain and disability, rheumatoid arthritis (RA) is also potentially the most treatable form of chronic arthritis. Researchers, doctors, and patients agree that a group of drugs called disease-modifying antirheumatic drugs (DMARDs) can effectively reduce joint pain and stiffness.

7 Jan 2005

Strong association between high levels of hyaluronic acid and severe osteoarthritis

A chronic degenerative joint disease, osteoarthritis (OA) is a common cause of pain and disability among older Americans. OA of the knee affects up to 6 percent of the older population, while OA of the hip affects about another 3 percent. While treatments vary, there is hope that early intervention – before joint destruction can be clearly seen and measured on an X-ray image-will improve outcomes.

7 Jan 2005

First program to apply RNA interference (RNAi) technology to asthma

Sirna Therapeutics, Inc. has announced the first program to apply RNA interference (RNAi) technology to asthma, a highly prevalent, chronic disease accounting for an estimated $13 billion in healthcare costs in the United States, a number which is forecast to grow considerably by the end of the decade.

7 Jan 2005

New guidelines for treating diabetes

Every year, the American Diabetes Association (ADA) issues Clinical Practice Recommendations, a series of updated recommendations to help health care providers treat people with diabetes using the most current research available.

7 Jan 2005

Peginterferon alfa-2b produced sustained responses in patients with chronic hepatitis B

Results from a large international clinical study reported in this week's issue of The Lancet showed that peginterferon alfa-2b produced sustained responses in patients with chronic hepatitis B. The investigator-initiated study is the largest clinical trial to date with peginterferon alfa-2b therapy for chronic hepatitis B.

7 Jan 2005

Ascorbic acid doesn't seem to help physical exercise performance

Orange juice or other sources of vitamin C (ascorbic acid), may (or may not) benefit you in terms of health and exercise, but contrary to what many people thought previously, ascorbic acid doesn't seem to help physical exercise performance.

6 Jan 2005

Women need less morphine after hysterectomies with new treatment

Women recovering from hysterectomies require less morphine to combat pain and are able to recover their lung function more quickly when they receive a combination of two non-morphine-like or “non-opioid” drugs as part of their treatment, a new Queen’s study shows.

5 Jan 2005

Chronic News and Research

Food, exercise and regular physical activity still key to American health

Scientific evidence on passive smoking is inconclusive

Smoking marijuana is associated with increased risk of many of the same symptoms as smoking cigarettes

Soy may reduce risk of cardiovascular disease

Added sugar in fruit-flavored drinks and cola-type soft drinks undoes the good done by vegetables

Major partnership with National Institute of Allergy and Infectious Diseases for Narhex Life Sciences

Researchers to test new leukemia drug

Latest Canadian mad cow case poses no threat

Campral, first new treatment for alcoholism in ten years

Patient education on aerosol therapy key to effective asthma control

Scientists examine the role of small sputum macrophages in the widespread disease chronic obstructive bronchitis

Core promoter mutants of Hepatitis B Virus e Antigen associated with development of fulminant hepatitis and liver cancer

Pegylated interferon alfa-2b offers the best treatment option for people with chronic hepatitis B infection

Promising new evidence for the optimal use of biologic therapies for rheumatoid arthritis

Strong association between high levels of hyaluronic acid and severe osteoarthritis

First program to apply RNA interference (RNAi) technology to asthma

New guidelines for treating diabetes

Peginterferon alfa-2b produced sustained responses in patients with chronic hepatitis B

Ascorbic acid doesn't seem to help physical exercise performance

Women need less morphine after hysterectomies with new treatment

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News